Back

Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding

29 August 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Optimising PCI: imaging, pharmacology and more Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Oskar Love Emilsson

Skane University Hospital, Lund (Sweden)

3 More presentations in this session

Presentation thumbnail
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.
Doctor G. Mendieta Badimon (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Intravascular ultrasound-guided optimization for chronic total occlusion-percutaneous coronary intervention with multiple drug-eluting stents
Doctor S. Seo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Shockwave intravascular lithotripsy (IVL) for calcified coronary lesions; a real world multicentre European study with long term follow up
Doctor W. Raja (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising PCI: imaging, pharmacology and more

The Event

Event poster

ESC Congress 2022

29 August 2022 00:00 CET
You may be interested in
thumbnail
Congress Session
Challenges in antiplatelet strategies in acute coronary syndromes: top tips for choosing wisely
thumbnail
Congress Presentation
Achieving immediate impact through intervention - clinical experiences
thumbnail
Congress Presentation
Pre-treatment in STEMI and non-STEMI: who, when, and how?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources